Method Of Use Patents Gaining Greater Importance In The Eyes Of Pharma
Executive Summary
Large pharmaceutical manufacturers are beginning to see method of use patents as a more valuable piece of their patent portfolios, Gene Logic CEO Mark Gessler said at the Biotechnology Industry Organization/Windhover Partnering Conference for Decision Makers in Washington, D.C. May 17